This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jun 12, 2026
Abbott's Libre Duo multianalyte sensors will have the same form factor as the Libre 3 Plus, 15-day wear time and compatibility with several insulin pump manufacturers.
Jun 10, 2026
Senseonics has partnered with Welldoc to build a new Eversense 365 smartphoapp with Apple and Google Health integration and AI-powered features.
May 27, 2026
Abbott's new Libre Duo sensors measure ketones and glucose levels simultaneously, and will be available in select European countries in late-2026.
May 26, 2026
Dexcom is urging patients and pharmacies to check lot numbers after two batches of scrapped CGM sensors were reportedly stolen and sold through a third party.
May 22, 2026
The G8's sleek design and new algorithm aims to solve past issues and is expected to be available to the public late 2027/early 2028.
May 18, 2026
The CGM offers real-time glucose monitoring for adults with type 2 diabetes not on intensive insulin therapy.
May 14, 2026
Dexcom’s next-gen G8 CGM is 50% smaller than the G7, last 15 days, and use self-adapting tech designed to improve accuracy. The company also teased future multi-analyte monitoring for potassium and ketones.
May 12, 2026
A side-by-side breakdown of the two most popular continuous glucose monitors used for diabetes management to help you choose which is right for you.
May 11, 2026
Not all continuous glucose monitors are evaluated equally, and as more people rely on CGMs for insulin dosing, that gap is becoming harder to ignore.
